Australia markets close in 5 hours 1 minute

Bellicum Pharmaceuticals, Inc. (BLCM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.4000+0.1200 (+9.38%)
At close: 03:58PM EST
1.4300 +0.03 (+2.14%)
After hours: 06:51PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
1,500
6,200
500
7,143
Operating expenses
Research development
20,472
23,578
39,052
64,535
Selling general and administrative
5,768
7,010
15,531
29,972
Total operating expenses
26,240
30,588
54,583
94,507
Operating income or loss
-24,740
-24,388
-54,083
-87,364
Interest expense
0
4
2,659
4,280
Total other income/expenses net
8,449
14,655
48,633
-22,184
Income before tax
-16,245
-9,705
-7,722
-112,477
Income from continuing operations
-16,245
-9,705
-7,722
-112,477
Net income
-16,245
-9,705
-7,722
-112,477
Net income available to common shareholders
-16,245
-9,705
-7,722
-112,477
Basic EPS
-
-0.84
-1.34
-24.01
Diluted EPS
-
-0.84
-1.34
-24.01
Basic average shares
-
11,504
5,760
4,685
Diluted average shares
-
11,504
5,760
4,685
EBITDA
-
-9,563
-3,189
-99,691